USANA Health Sciences "neutral," target price raisedNEW YORK, February 7 (newratings.com) - Analyst Timothy S Ramey of DA Davidson maintains his "neutral" rating on USANA Health Sciences Inc (USNA.NAS), while raising his estimates for the company. The target price has been raised from $54 to $56.
In a research note published this morning, the analyst mentions that the company has reported its 4Q EPS ahead of the estimates and the consensus due to gains from favourable foreign exchange valuation. USANA Health Sciences’ sales for the quarter were boosted by robust sales growth in the US, Mexico and the Asia Pacific region, the analyst says. The company has raised its EPS guidance for FY07. The EPS estimate for 2007 has been raised from $2.55 to $2.57.
